Lesinurad

Entity type image
Type: Product
Name: Lesinurad
First reported May 03 2013 - Updated May 03 2013 - 1 reports

A.P. Pharma: Management Change Is A Positive For The Stock

IntroductionThis report deals with the just announced management change at A.P. Pharma (APPA.OB) and the positive impact that I believe it will have on the stock. It does not get into an in-depth discussion of the fundamentals and financial projections ... [Published Seeking Alpha - May 03 2013]

More Content

All (6) | News (0) | Reports (1) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
A.P. Pharma: Management Change Is A Positive Fo... [Published Seeking Alpha - May 03 2013]
ASTRAZENECA OUTLINES STRATEGY TO RETURN TO GROW... [Published CisionWire - English - Mar 21 2013]
DOTW: Wall Street Hopes AstraZeneca is the Next... [Published The IN VIVO Blog - Jan 18 2013]
M&A Deal of the Year Nominee Bristol-Myers/Amyl... [Published The IN VIVO Blog - Dec 18 2012]
The Launch of Febuxostat and the Anticipated La... [Published EON Health & Medicine - Dec 05 2012]
The Launch of Febuxostat and the Anticipated La... [Published Business Wire Health News - Dec 05 2012]
1
In Focus
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
DOTW: Wall Street Hopes AstraZeneca is the Next... [Published The IN VIVO Blog - Jan 18 2013]
Wall Street is hoping AstraZeneca will buy its way out of its current conundrum. The pharma jumped off the proverbial patent cliff last year and is expected to slide for the foreseeable future. Analysts' model for a turnaround of the beleaguered British ...
M&A Deal of the Year Nominee Bristol-Myers/Amyl... [Published The IN VIVO Blog - Dec 18 2012]
It's time for the IN VIVO Blog's Fifth Annual Deal of the Year! competition. This year we're once again presenting awards in three categories to highlight the most interesting and creative deal making solutions of the year. The categories are: M&A ...
1

Press Releases

sort by: Date | Relevance
ASTRAZENECA OUTLINES STRATEGY TO RETURN TO GROW... [Published CisionWire - English - Mar 21 2013]
The Launch of Febuxostat and the Anticipated La... [Published EON Health & Medicine - Dec 05 2012]
The Launch of Febuxostat and the Anticipated La... [Published Business Wire Health News - Dec 05 2012]
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.